Psoriasis
Conference Coverage
PsA prediction tool approaches clinical utility
A tool to identify patients with psoriasis at high risk of psoriatic arthritis appears near to clinical application.
The Optimized Doctor
Could ChatGPT write this column?
I asked ChatGPT to write an article about itself in the style of Christopher Hitchens. It was nothing like his incisive and eloquent prose, but it...
Feature
Health plans get very poor scores for access to autoimmune drugs
Three out of four insurance plans use policies that result in significant to severe restriction of access to medications for seven autoimmune...
Latest News
First Humira biosimilar launches in U.S.
Amgen’s Amjevita will be offered at 5% and 55% below Humira’s list price, but patients may not benefit from the more significant discount.
Case Letter
Generalized Pustular Psoriasis Treated With Risankizumab
Generalized pustular psoriasis (GPP) is a potentially life-threatening condition that can be precipitated by systemic steroids.
Original Research
Adverse Effects of the COVID-19 Vaccine in Patients With Psoriasis
Patients who have psoriasis do not appear to have an increased incidence of adverse effects from messenger RNA COVID-19 vaccines.
Commentary
More New Therapeutics for Psoriasis
New treatments for psoriasis constitute an embarrassment of riches compared to any other area of dermatology. Despite the many advances over the...
Clinical Review
New Treatments for Psoriasis: An Update on a Therapeutic Frontier
This review aims to present the mechanisms and data on both newly available therapeutics for psoriasis and products in the pipeline that may have...
Latest News
Elevated PCSK9 levels associated with psoriasis suggest new treatment target
A large population analysis implicates PCSK9 as a target in prevention of psoriasis.
From the Journals
Fluorescence-optical imaging may detect preclinical PsA
Identification of microscopic blood vessel changes may point to psoriatic arthritis before clinical symptoms appear.
Commentary
75 years: A look back on the fascinating history of methotrexate and folate antagonists
Dr. David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate’s...